SCHEMBL14128245

SCHEMBL14128245

Fc1ccc(-c2nc3cc(F)c(F)cc3[nH]2)cn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.60
▸ KDM4E B2RXH2 3/20 0.60
▸ HPGD P15428 2/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ CYP3A4 P08684 1/20 0.60
▸ CYP2D6 P10635 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ CBFB Q13951 1/20 0.52
▸ CYP11B2 P19099 1/20 0.51
▸ DGAT1 O75907 3/20 0.49
▸ NPC1 O15118 4/20 0.48
▸ KCNH2 Q12809 2/20 0.47
▸ CYP11B1 P15538 1/20 0.47
▸ ADORA2A P29274 1/20 0.45
▸ TCF4 P15884 1/20 0.43
▸ CTNNB1 P35222 1/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ PKM P14618 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14128551 0.84 CYP11B1 (0.65) ALDH1A1KDM4ECBFBDGAT1NPC1
SCHEMBL16121162 0.82 KDM4E (0.55) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL1687838 0.81 NPC1 (0.58) ALDH1A1KDM4EHPGDCYP3A4HSD17B10
SCHEMBL15626605 0.81 NPC1 (0.50) ALDH1A1KDM4EHPGDHSD17B10NPC1
SCHEMBL24075325 0.80 KDM4E (0.73) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL24075329 0.80 KDM4E (0.68) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL12402878 0.79 NPC1 (0.68) ALDH1A1KDM4EHPGDHSD17B10NPC1
SCHEMBL4559600 0.79 NPBWR1 (0.55) DGAT1KCNH2NPBWR1
SCHEMBL24075316 0.78 KDM4E (0.69) ALDH1A1KDM4EHPGDCYP1A2CYP3A4
SCHEMBL24075246 0.78 ALDH1A1 (0.69) ALDH1A1KDM4EHPGDCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140088124-A1 IMIDAZOLE DERIVATIVES INTERVET INC. 2014-03-27 — — US disclosed
US-20140088124-A1 IMIDAZOLE DERIVATIVES INTERVET INC. 2014-03-27 — — US disclosed
US-20140088124-A1 IMIDAZOLE DERIVATIVES INTERVET INC. 2014-03-27 — — US disclosed
WO-2012164071-A1 IMIDAZOLE DERIVATIVES INTERVET INTERNATIONAL B.V. (NL) 2012-12-06 — — WO disclosed
WO-2012164071-A1 IMIDAZOLE DERIVATIVES INTERVET INTERNATIONAL B.V. (NL) 2012-12-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088124-A1 IMIDAZOLE DERIVATIVES DGAT1, DGAT2, SOAT1 ALDH1A1 196/4885KDM4E 2982/4885HPGD 881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback